Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1402582

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1402582

Preterm Birth and PROM Testing Market, By Product Type, By Test Type, By End User, By Geography

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The preterm birth and PROM testing market size is expected to reach US$ 2.6 Bn by 2030, from US$ 1.7 Bn in 2023, at a CAGR of 6.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.7 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.30% 2030 Value Projection: US$ 2.6 Bn
Figure 1. Global Preterm Birth and PROM Testing Market Share (%), by Region, 2023
Preterm Birth and PROM Testing Market - IMG1

Preterm birth, also known as premature birth, is a significant global health concern. It refers to the birth of a baby before 37 completed weeks of gestation. According to the World Health Organization (WHO), around 15 million babies are born prematurely each year, accounting for approximately one in 10 births worldwide. Preterm birth can lead to various health complications and is one of the leading causes of neonatal mortality and morbidity.

PROM testing, which stands for prelabor rupture of membranes, is an important diagnostic tool used to assess the risk of preterm birth. It helps in the early detection of membrane rupture before the onset of labor. By detecting the presence of amniotic fluid, PROM testing helps healthcare professionals make informed decisions regarding the management and care of pregnant women at risk of premature birth.

Market Dynamics:

The preterm birth and PROM testing market is primarily driven by the increasing incidence of preterm births worldwide. Factors, such as maternal age, multiple pregnancies, poor prenatal care, infections, and socioeconomic factors, contribute to the rise in preterm births. PROM testing plays a crucial role in identifying the risk of preterm birth, enabling healthcare professionals to provide timely interventions and improve neonatal outcomes.

However, there are certain restraints that can hinder the growth of the market. These include the high cost of PROM testing kits, limited access to healthcare facilities in developing regions, and the lack of awareness about preterm birth and PROM testing among pregnant women and healthcare providers.

On the other hand, there are significant opportunities in the market, driven by technological advancements in PROM testing methods, increasing focus on point-of-care testing, and the growing demand for personalized medicine. Market players are investing in research and development activities to develop innovative PROM testing kits with improved accuracy, ease of use, and cost-effectiveness.

Overall, the preterm birth and PROM testing market is witnessing substantial growth, driven by the increasing awareness about preterm birth, advancements in PROM testing methods, and the need for early detection and intervention to improve neonatal outcomes. Market players are strategizing to expand their product portfolios, collaborate with key stakeholders, and explore the untapped market potential.

Key Features of the Study:

  • This report provides an in-depth analysis of the global preterm birth and PROM testing market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preterm birth and PROM testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Biosynex, Qiagen N.V., Clinical Innovations, LLC, Sera Prognostics, Hologic, Inc., IQ Products, NX Prenatal, Inc., PROMega Corporation, Insight Pharmaceuticals LLC, and Creative Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global preterm birth and PROM testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preterm birth and PROM testing market

Detailed Segmentation:

  • By Product Type
    • Kits and Reagents
    • Instruments
    • Consumables
  • By Test Type
    • Pelvic exam
    • Ultrasound
    • Uterine monitoring
    • Biomarker testing
    • Others
  • By End User
    • Hospitals
    • Diagnostics laboratories
    • Outpatient clinics
    • Research centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Preterm Birth and PROM Testing Market
    • Abbott Laboratories
    • Biosynex
    • Qiagen Sciences LLC
    • Clinical Innovations, LLC
    • Sera Prognostics
    • Hologic, Inc.
    • IQ Products
    • NX Prenatal, Inc.
    • Promega Corporation
    • Medical predictive Technologies Inc.
    • Creative Diagnostics
Product Code: CMI6403

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Preterm Birth And PROM Testing Market, By Product Type
    • Preterm Birth And PROM Testing Market, By Test Type
    • Preterm Birth And PROM Testing Market, By End User
    • Preterm Birth And PROM Testing Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of preterm births
    • High costs of prenatal diagnostic tests
    • Significant untapped potential in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Type Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Preterm Birth and PROM Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Preterm Birth and PROM Testing Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Kits and Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

6. Preterm Birth and PROM Testing Market, By Test Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pelvic exam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Ultrasound
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Uterine monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Biomarker testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Preterm Birth and PROM Testing Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Diagnostics laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Outpatient clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Research centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Preterm Birth and PROM Testing Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biosynex
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Qiagen N.V.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Clinical Innovations, LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sera Prognostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IQ Products
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NX Prenatal, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Insight Pharmaceuticals LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Creative Diagnostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!